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Results:
 
 The AV conduction time increased over the time in all groups (Z-
score: from 0.9±1.1 to 1.3±0.9 in G1, 0.9±1.2 to 1.7±1.6 in G2 and 0.7±0.7 to
1.4±1.3 in G3). One G2 patient and two G3 patients had increased PQ duration
>200 msec at late follow-up. The QRS duration increased during the follow-
up at a rate of 1.78 msec/year in G1, 2.34 msec/year in G2 despite pulmonary
valve replacement in 10 patients, and 1.81 msec/year in G3 despite conduit
replacement in 9. At the later follow-up, the QRS duration was significantly
increased (Z-score: 4.5±3.6 in G1, 5.7±1.4 in G2 and 4.6±1.9 in G3). One
patient in each group had QRS duration of 170 msec or longer and the one in
G3 had a history of serious ventricular arrhythmia. Three patients had a QTc
duration above 460 msec.
 
Conclusions:
 
 Conduction disorders are noted at late follow-up in Fallot
patients who received transannular patch but also in those who received no
patch or a pulmonary homograft. It suggests that volume overloading related
to the transannular patch but also chronic pressure overloading and myocardial
injury related to surgery also contribute to the development of conduction dis-
orders. We suggest that all Fallot patients should undergo regular ECG follow-
up and that, in those with signs of conduction disorders, further diagnostic pro-
cedures should be considered.
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Percutaneous closure of atrial septal defects in children : what are the
predictive factors of success ?
 
Elise Barre (1), Jerome Petit (2), Jean Losay (2), Andre Capderou (3),
Bertrand Stos (2), Antoine Legendre (2), Alain Serraf (2), Virginie Lam-
bert (2)
 
(1) Hôpital Européen Georges Pompidou, Paris, France - (2) Centre 
chirurgical Marie Lannelongue, Service des Cardiopathies Congénitales, 
Le Plessis Robinson, France - (3) INSERM U-999, Le Plessis Robinson, 
France
Introduction:
 
 Percutaneous atrial septal defect (ASD) closure is now a
safe and efficient alternative to surgery in adults. In paediatric population, its
feasibility is still uncertain and limited in young children with large defect.
Our aim was to determine predictive factors of success of percutaneous ASD
closure in this population. 
 
Methods:
 
 All patients less than 12 years-old who underwent an attempt of
a percutaneous ASD closure using Amplatzer septal occluder device were ret-
rospectively reviewed. We analysed by echocardiography ASD diameter,
length of rims surrounding, length of atrial septum, and during catheterization
balloon-stretched diameter. ASD area was calculated and normalized to the
body surface area of patients. The procedure was abandoned when the device
placement failed after three attempts. 
 
Results:
 
 140 patients (age 7.7±2.5 years, weight 25.3±9 kg) were included.
Echocardiographic ASD diameter was 15±4.1 mm, balloon-stretched diameter
19.8±4.7mm, length of atrial septum 34.8±5.9 mm, diameter of implanted
device 18.6±4.3 mm. All rims surrounded ASD measuring at least 3 mm. Per-
cutaneous closure was successfully performed in 131 patients and failed in
8 patients. One device embolization into right atria occurred without any com-
plication leads to surgery. Predictive factors of success included smaller ASD
echocardiographic and balloon-stretched diameters (14.6±3.8 vs 19.9±4.4 mm,
p<0.001 and 19.0±0.6 vs 25.6±6.3 mm, p<0.001), smaller ratio ASD area/
body surface area (338±139 vs 569±210, p<0.05), smaller device size
(18.3±3.9 vs 22.4±5.7 mm, p<0.05), and smaller gap between balloon-
stretched and implanted device diameters (-1.0±0.6 vs 3.1±2.8 mm). 
 
Conclusion: 
 
Percutaneous ASD closure using Amplatzer device is feasible
and safe in most of children. Small ASD and an appropriate size device are
predictive of success. In the larger ASD and in the younger patients, normal-
ization of ASD area to body surface area may help to choice the best treat-
ment.
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Despite permanent progress in medical treatments, primary pulmonary
hypertension in children (PPHTC) remains a not curable disease with a severe
prognosis. Moreover, continuous intravenous treatment is particularly unac-
ceptable for the quality of survival at this age.
 
Background:
 
 Eisenmenger syndrome with large patent ductus arteriosus
carries a relatively good prognosis with long-term survival. This prompted us
to try a Potts anastomosis as surgical palliative treatment for PPHTC : direct
anastomosis between the descending aorta and the left pulmonary artery
without cardiopulmonary bypass. 
 
Aim:
 
 To assess the risks and benefits of that surgery and the mid-term
results in the first cases.
 
Material and methods:
 
 From 06/05/2004 to 23/03/2007, six children
underwent Potts anastomosis for PPHTC. Age was 2.4 to 11 years, weight 14
to 23 Kg. All were NYHA IV and experienced syncopes. All received
Bosentan, associated with continuous intravenous prostacyclin in 4 and
Sildenafil in 1. Bosentan was used in monotherapy in 1.
 
Immediate results: 
 
No death occurred during surgery.
One child died at day 12 with staphylococcus infection and major cyanosis.
This child received Bosentan monotherapy.
 
Mid term results: 
 
No death occurred during a mean follow-up of 4 years
and 2 months. For the 5 surviving patients, functional status increased from
NYHA IV to NYHA I (3 pts) and NYHA II (2 pts). No syncope occurred.
Intravenous prostacyclin therapy was stopped for 3/4 pts who received it
before. Oral treatment was continued. Potts anastomosis remained large with
right to left shunt and same pressure in pulmonary arteries and aorta. Percuta-
neous oxygen saturation in inferior limbs is stable, from 88 to 72 %, and
normal in right upper limb. All have mild to moderate polycythaemia.
 
Conclusion:
 
 Surgical Potts anastomosis is a palliative solution for PPHTC
with an acceptable perioperative risk and good mid-term results. It avoids
sudden death and allows a better quality of life in these children.
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Introduction:
 
 Kawasaki disease is the leading cause of acquired heart dis-
ease in children. Increased cardiovascular risk can be assessed by intima-
media thickness (IMT), a strong independent predictive factor for coronary
heart disease, as could be the flow-mediated vasodilatation (FMD).  However,
controversy exists about these parameters if altered in children with Kawasaki
disease.
 
Objective:
 
 The aim of our study was to study the mechanical arterial prop-
erties and to analyze endothelial function by measuring the flow-mediated
dilatation proving its alteration in Kawasaki disease patients evolving with
moderate or without coronary artery lesions. 
 
Population and methods:
 
 A study design of 29 patients who had
Kawasaki disease with no or transient or coronary artery involvement less than
4 mm of dilatation (group I), mean age 7,6 years, was compared to 30 healthy
age-matched children (group II), mean age of 8,3 years. The carotid IMT,
incremental elastic modulus, cross sectional compliance,distensibility and
FMD were determined non-invasively one year following the disease. 
 
Results:
 
 No significant difference was found with Flow-Mediated Dilata-
tion between either group, for group I (9,16 %, Standard Deviation:
SD = 5,05) and group II (8,8 %, SD = 4,56). As it was for mechanical arterial
properties, like incremental elastic modulus, vascular compliance, distensi-
bility and IMT, for group I (Mean IMT = 0,44 mm, SD = 0,028) vs (0,46 mm,
SD = 0,060) for group II.
 
Conclusions:
 
 Early evaluation of mechanical properties and endothelial
function of the arteries in patients with Kawasaki disease, who have no or little
dilatation less than 4 mm in coronary arteries, don’t show any alteration as
compared with healthy population.  
 © Elsevier Masson SAS. All rights reserved.
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However, this non-invasive test could be performed to a larger population of
Kawasaki patients described above, in a prospective study with repeated mea-
surements and follow up at different ages to confirm the absence of cardiovas-
cular risk.
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Introduction:
 
 Right heart failure is a common feature in patients with
repaired tetralogy of Fallot (TOF), right ventricular (RV) dysfunction and right
bundle branch block (RBBB). Biventricular pacing (BVP) has been described
as a potentially useful therapeutic in some cases. We aimed to investigate the
clinical outcome and dyssynchrony echocardiographic characteristics of
patients with repaired TOF and BVP.
 
Methods:
 
 A systematic retrospective study of all of the patients of CHU de
Bordeaux with repaired TOF and BVP was realized. Clinical NYHA status
and exercise test performance were retrieved before and 6 months after BVP.
All patients benefited from an echocardiography with dyssynchrony measures
in spontaneous rhythm, RV pacing and BVP.
 
Results:
 
 10 patients (7 male, 36,6 ± 13 years old) were retrieved from our
database. Surgical repair had occurred at the age of 7,4 ± 5,8 years. BVP was
effective since 18 ± 10 months.
After 6 months of BVP were noted a significant improvement in NYHA class
(1,3 ± 0,4 vs 1,8 ± 0.6,  p=0.05) and exercise test capacity (93 ± 22 W vs
78 ± 14 W, p<0,05). 
In spontaneous rhythm (SR), a significant inter-ventricular dyssynchrony was
found (41 ± 13 ms, p<0,01) as well as late activation of RV lateral wall (elec-
trosystolic delay: 42 ± 22 ms vs lateral LV wall and 49 ± 30 ms vs interven-
tricular septum; p<0,01 for both).  This dyssynchrony is corrected in
biventricular pacing (inter-ventricular delay 8,6 ± 6,4 ms electrosystolic delays
repectively 25,5 ± 13 ms and  12 ± 9 ms, p<0,01 vs SR). RV pacing is respon-
sible for late activation of LV lateral wall (36,5 ± 30 ms)
 
Conclusion:
 
 BVP pacing in selected patients with repaired TOF, BVP sig-
nificantly improves dyssynchrony parameters. This is associated with signifi-
cative improvement of clinical status.
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Introduction:
 
 In our centre, device closure is the first-intention therapy for
secundum atrial septal defect (ASD). In difficult cases we use a Meditech
sizing balloon to optimize position of the device. We sought to determine (1)
the efficacy of this sizing balloon-assisted technique (SBT) and (2) the per-
centage of ASDs that can be percutaneously closed. 
 
Patients:
 
 In 2009, 65 patients (37 female) were referred for secundum
ASD closure, at a median age and weight of 27.5(0.8 to 88) years and 40.6(5.6
to 97) kg, respectively. Six had pulmonary hypertension. 
 
Results:
 
 Eight patients had surgical closure because of referral cardiologist
and/or patient’s choice. Among the 57 remaining patients, 4 were unsuitable
by echocardiography and surgically closed. Transcatheter closure was
attempted in 53 cases, including 28 children (53%), and was successful in
50 cases, including 10 with SBT (20%). Amplatzer devices were used in all
the patients with a median Amplatzer septal occluder (ASO) size of 20 (10 to
40)mm. A 12 mm ASO could not be positioned in a 5.6 kg infant. Surgical
closure was contraindicated for poor general condition (former 26 weeks pre-
mature baby with severe bronchodysplasia). Transcatheter closure failed in
2 cases, despite SBT. No major complication occurred. Five patients (10%)
had a trivial residual shunt. By univariate analysis, the deficiency of superior
rim (<5mm from the defect) and a large ASD size were associated with the
use of SBT (p= 0.04 and 0.002, respectively). The deficiency of superior rim
and pulmonary hypertension (mean > 25mmHg) were associated with failure
to percutaneously close the ASD (p= 0.02 and 0.03, respectively). Out of
57 patients candidates for transcatheter closure, 50 were successfully closed
percutaneously (87%). 
 
Conclusion:
 
 Transcatheter closure of ASD is successfully accomplished in
the majority of the cases. The SBT is safe and useful for device positioning
and delivery in patients with large ASDs and deficient superior rim. 
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Introduction: Diffuse pulmonary vein stenosis (PVS) is a profoundly
debilitating disease, leading to right ventricular failure and death. We sought
to determine whether transcatheter interventional approach may improve
patient’s survival. 
Patients: Since 2005, 4 children presented with PVS, congenital in 3 cases,
including one associated with single ventricle (SV). One patient had acquired
PVS after repair of total anomalous pulmonary venous connection. Surgical
repair of the PVS was performed in 3 patients, who underwent 2, 3 and 4 oper-
ations, respectively. All of them developed restenosis within 3 to 10 weeks
(median: 5.5 weeks). In one patient, former 26 weeks premature baby with
severe bronchopulmonary dysplasia, surgery was contraindicated and tran-
scatheter therapy considered first. 
Results: Six catheterizations were performed in the 4 patients at a median
age and weight of 18 (6 to 28) months and 7.7(4.6 to 9.3)kg, respectively.
Eleven interventions were performed, including high pressure balloon dilation
(n=5), bare stent implantation (n=3) and drug-eluting stent implantation (n=3).
One patient had bare stent implantation with coated-balloon dilation as a
hybrid procedure. High pressure balloon dilation failed in all cases. Stent
implantations were successful in all cases. One patient with right ventricular
failure died. The 3 remaining patients improved their functional status. The
patient with SV had heart-lung transplantation 6 months after drug-eluting
stent implantation. She subsequently died from postoperative infection. Two
patients are alive and being well, 4 and 16 months after stent implantation. 
Conclusion: Transcatheter management may prolong survival or can be
successful as a bridge to heart-lung transplantation. This should be consider as
an interesting alternative of surgery. 
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Agenesis of the ductus venosus is a rare anomaly that may be responsible
of cardiomegaly and hydrops in fetuses. We report 2 cases in combination
with pulmonary artery hypertension (PAH).
Agenesis of ductus venosus was diagnosed in 2 boys at the second term of
pregnancy. None had associated hydrops. Chromosomal karyotyping was
